CD8A and neoplasm: In addition, although the ex vivo expansion of T-cells preferentially expands the number of CD8-positive cytotoxic T-cells (16, 23), these cells are not tumor specific, which hinders their ability to break tolerance and engage in vivo targets on malignant cells.